{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:54:16Z","timestamp":1787759656552,"version":"build-2784847793"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1097\/tp.0000000000002520","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T23:33:23Z","timestamp":1541547203000},"page":"e58-e58","source":"Crossref","is-referenced-by-count":16,"title":["Safety and Efficacy of PCSK9 Inhibitor Treatment in Heart Transplant Patients"],"prefix":"10.1097","volume":"103","author":[{"given":"Concetta","family":"Di Nora","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sponga","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugolino","family":"Livi","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Science, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jchf.2017.09.014","article-title":"Changes in outcomes of cardiac allograft vasculopathy over 30 years following heart transplantation.","volume":"5","author":"Tremblay-Gravel","year":"2018","journal-title":"JACC Heart Fail"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator.","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/j.transproceed.2011.08.052","article-title":"In the era of the universal use of statins dyslipidemia\u2019s are still common in heart transplant recipients: a crosssectional study.","volume":"8","author":"Zakliczynski","year":"2011","journal-title":"Transplant Proc"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bcp.12367","article-title":"Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.","volume":"78","author":"van Staa","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2017.07.745","article-title":"2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on expert consensus decision pathways.","volume":"14","author":"Lloyd-Jones","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:25:24Z","timestamp":1696224324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002520","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}